Asan Pharmaceutical
485, Cheonggyecheon-ro, Seoul, Dongdaemun-gu, 02589, South Korea
Overview
Asan Pharmaceutical specializes in the production and sale of in vitro diagnostic reagents and equipment, laboratory instruments and equipment, and media. They import manufacturing, and distributing a wide range of diagnostic reagents, including hepatitis diagnostic reagents, to the clinical testing industry, which was a void at the time.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- Pamir Therapeutics
Led · Equity · Sep 2023
Asan Pharmaceutical entered a strategic investment and commercial partnership with (주)파미르테라퓨틱스 (Pamir Therapeutics), committing 20억원 as a strategic investor. Under the agreement, Pamir Therapeutics will handle research, development and supply of a Parkinson’s disease in‑vitro diagnostic kit while Asan holds the domestic exclusive distribution rights. Asan will be responsible for sales and marketing activities for the kit in the domestic market. The funding was described in the articles as a strategic investment (SI). The announcement was covered by multiple outlets including Biospectator, Biotimes, Hankyung, Herald Economy and Medical Today. No other financial terms or additional investors were disclosed in the referenced coverage.
Team
No current team members are available.